• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

    1.760 +0.030 (+1.73%)
    Streaming Delayed Price Updated: 3:19 PM EDT, May 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about InMed Pharmaceuticals Inc. - Common Shares

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    News headline image
    Halper Sadeh LLC is Investigating Whether SEM, WSR, INM, GDOT are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    InMed Pharmaceuticals Amends Preferred Investment Options
    Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused... 
    Via Newsfile
    Discover the top movers in Tuesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for December 11th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    In today's session, these stocks are experiencing unusual volume. ↗
    On Thursday, there are stocks with unusual volume. Let's take a look. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    What's Driving InMed's (INM) 22% After-Hours Surge? ↗
    InMed shares jumped 22% in after-hours trading after the company reported encouraging large-animal study results for its Alzheimer's drug candidate INM-901. 
    Via Benzinga
    News headline image
    Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Life Science Virtual Investor Forum Agenda Announced for September 18th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Get insights into the top gainers and losers of Monday's after-hours session. ↗
    Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
    Via Chartmill
    News headline image
    Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data ↗
    Cognition Therapeutics Inc (NASDAQ: CGTX) continued to gain 12.10% in after-hours trading on Thursday, after a 20.82% surge during regular market hours. 
    Via Benzinga
    News headline image
    InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
    Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused... 
    Via Newsfile
    Topics Regulatory Compliance
    News headline image
    InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
    Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused... 
    Via Newsfile
    Topics Regulatory Compliance
    News headline image
    Here are the top movers in Tuesday's session. ↗
    Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
    Via Chartmill
    BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model
    Via Investor Brand Network
    News headline image
    Curious about the most active stocks on Tuesday? ↗
    Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
    Via Chartmill
    News headline image
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Looking for insights into the US markets in the middle of the day on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
    Via Chartmill
    News headline image
    Which stocks are gapping on Tuesday? ↗
    The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
    Via Chartmill
    News headline image
    Why InMed's Alzheimer's Drug Candidate Is Fueling Sudden Stock Surge ↗
    InMed stock jumped after preclinical data showed INM-901 lowered brain inflammation tied to Alzheimer's and improved cognitive function in models. 
    Via Benzinga
    News headline image
    Tuesday's pre-market session: top gainers and losers ↗
    Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study
    Demonstrates statistically significant reduction of pro-inflammatory cytokines, including IL-6, IL-1β, IL-2, and KC/GroSignificantly reduces levels of inflammasome marker, NLRP3, a... 
    Via Newsfile
    News headline image
    Which stocks are experiencing notable movement on Monday? ↗
    Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
    Via Chartmill
    News headline image
    Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings ↗
     
    Via Benzinga
    Topics Stocks
    News headline image
    Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.